SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Farmers Vs. Monsanto: Glyphosate Showdown Comes to US Court in San Francisco
“Science Week” in a federal court will decide if farmer cancer lawsuits move forward.
Mar 05, 2018
WASHINGTON
WASHINGTON
A federal court hearing in San Francisco this week will turn a spotlight on the science surrounding the world's most widely used pesticide, glyphosate, and determine whether farmers and their families will be able to proceed with legal action against Monsanto Co. over cancer concerns.
More than 365 lawsuits are pending against Monsanto in U.S. District Court in San Francisco, filed by people alleging that exposure to Roundup herbicide caused them or their loved ones to develop non-Hodgkin lymphoma, and that Monsanto covered up the risks.
The court has dubbed the March 5-9 events as "science week" because the only evidence to be presented will come from experts in cancer science, including epidemiologists, toxicologists, and biomedical statistical analysts called to analyze relevant research. The scientists will present their best scientific evidence to U.S. Judge Vince Chhabria, who will decide if the lawsuits move forward or are halted in their tracks.
Journalist and author Carey Gillam of U.S. Right to Know will be live blogging the event from the courthouse. Follow her posts here: https://usrtk.org/live-updates-monsanto-hearing/
Gillam is author of "Whitewash: The Story of a Weed Killer, Cancer and the Corruption of Science" (Island Press, 2017) -- "a gutsy, compelling read from beginning to end, especially for readers who enjoy the kind of hard-nosed, shoe-leather reporting that used to be the hallmark of great journalism," according to the Society for Environmental Journalists' BookShelf review.
Gillam is also research director of U.S. Right to Know, a consumer and public health watchdog group. USRTK is posting documents and analysis from the MDL glyphosate cancer cases on our Monsanto Papers webpage.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
A federal court hearing in San Francisco this week will turn a spotlight on the science surrounding the world's most widely used pesticide, glyphosate, and determine whether farmers and their families will be able to proceed with legal action against Monsanto Co. over cancer concerns.
More than 365 lawsuits are pending against Monsanto in U.S. District Court in San Francisco, filed by people alleging that exposure to Roundup herbicide caused them or their loved ones to develop non-Hodgkin lymphoma, and that Monsanto covered up the risks.
The court has dubbed the March 5-9 events as "science week" because the only evidence to be presented will come from experts in cancer science, including epidemiologists, toxicologists, and biomedical statistical analysts called to analyze relevant research. The scientists will present their best scientific evidence to U.S. Judge Vince Chhabria, who will decide if the lawsuits move forward or are halted in their tracks.
Journalist and author Carey Gillam of U.S. Right to Know will be live blogging the event from the courthouse. Follow her posts here: https://usrtk.org/live-updates-monsanto-hearing/
Gillam is author of "Whitewash: The Story of a Weed Killer, Cancer and the Corruption of Science" (Island Press, 2017) -- "a gutsy, compelling read from beginning to end, especially for readers who enjoy the kind of hard-nosed, shoe-leather reporting that used to be the hallmark of great journalism," according to the Society for Environmental Journalists' BookShelf review.
Gillam is also research director of U.S. Right to Know, a consumer and public health watchdog group. USRTK is posting documents and analysis from the MDL glyphosate cancer cases on our Monsanto Papers webpage.
A federal court hearing in San Francisco this week will turn a spotlight on the science surrounding the world's most widely used pesticide, glyphosate, and determine whether farmers and their families will be able to proceed with legal action against Monsanto Co. over cancer concerns.
More than 365 lawsuits are pending against Monsanto in U.S. District Court in San Francisco, filed by people alleging that exposure to Roundup herbicide caused them or their loved ones to develop non-Hodgkin lymphoma, and that Monsanto covered up the risks.
The court has dubbed the March 5-9 events as "science week" because the only evidence to be presented will come from experts in cancer science, including epidemiologists, toxicologists, and biomedical statistical analysts called to analyze relevant research. The scientists will present their best scientific evidence to U.S. Judge Vince Chhabria, who will decide if the lawsuits move forward or are halted in their tracks.
Journalist and author Carey Gillam of U.S. Right to Know will be live blogging the event from the courthouse. Follow her posts here: https://usrtk.org/live-updates-monsanto-hearing/
Gillam is author of "Whitewash: The Story of a Weed Killer, Cancer and the Corruption of Science" (Island Press, 2017) -- "a gutsy, compelling read from beginning to end, especially for readers who enjoy the kind of hard-nosed, shoe-leather reporting that used to be the hallmark of great journalism," according to the Society for Environmental Journalists' BookShelf review.
Gillam is also research director of U.S. Right to Know, a consumer and public health watchdog group. USRTK is posting documents and analysis from the MDL glyphosate cancer cases on our Monsanto Papers webpage.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.